Abstract:Background Several cardioprotective mechanisms attributed to n-3 polyunsaturated fatty acids (PUFAs) have been widely documented. Significant interest has recently focused on the role of human gut microbiota in metabolic disorders. However, the role of plant-derived n-3 PUFAs on blood lipid profiles is controversial and the effect on gut microbiota is still unclear. Objectives We aimed to perform a double-blind randomized controlled trial to test the effect of plant-derived n-3 PUFAs on the blood lipids and gut microbiota of patients with marginal hyperlipidemia. Methods According to the inclusion and exclusion criteria, 75 participants with marginal hyperlipidemia were randomly assigned to the intervention group (supplied with n-3 PUFA-enriched plant oil) or control group (supplied with corn oil), respectively, for a 3-month treatment. Participants and assessors were blinded to the allocation. The primary outcomes of the trial were the changes in serum lipid levels. Secondary outcomes were changes in gut microbiota and metabolites. For the primary outcomes, we conducted both an intent-to-treat (ITT) analysis and a per protocol (PP) analysis. For the secondary outcomes, we only conducted the PP analysis among the participants who provided fecal sample. Results Fifty-one participants completed the trial. Relative to the control group, the n-3 PUFA supplementation resulted in significant reduction in total cholesterol (TC) levels (−0.43 mmol/L, 95% CI−0.84 to−0.01 mmol/L, P < 0.05). The n-3 PUFA supplementation was also associated with significantly increased relative abundance of Bacteroidetes in phylum level ( P < 0.01; false discovery rate (FDR) corrected p = 0.11), and decreased the ratio between Firmicutes and Bacteroidetes ( P < 0.05; FDR corrected p = 0.16). At genus level, the intervention of plant derived n-3 PUFAs resulted in a significant decrease in relative abundance of Phascolarctobacterium ( P < 0.01; FDR corrected p = 0.18) and Veillonella ( P < 0.01; FDR corrected p = 0.18) after the intervention. Conclusions Our results demonstrated that plant-derived n-3 PUFAs beneficially affected the serum levels of TC and decreased the ratio between Firmicutes and Bacteroidetes during the 12-week intervention period, which might confer advantageous consequences for lipid metabolism and intestinal health.

Effects of n-6 PUFA-rich soybean oil, MUFA-rich olive oil and camellia seed oil on weight and cardiometabolic profiles among Chinese women: a 3-month double-blind randomized controlled-feeding trial

Effects of n-3 fatty acid supplements on cardiometabolic profiles in hypertensive patients with abdominal obesity in Inner Mongolia: a randomized controlled trial.

Effects of Dietary Olive Oil, Camellia Seed Oil and Soybean Oil on Serum Lipid Composition in Women with a High Risk of Cardiovascular Disease: a Lipidomic Analysis

Effect of N-3 and N-6 Polyunsaturated Fatty Acids on Lipid Metabolic Genes and Estrogen Receptor Expression in MCF-7 Breast Cancer Cells.

Effects of Different N-6/N-3 Polyunsaturated Fatty Acids Ratios on Lipid Metabolism in Patients with Hyperlipidemia: a Randomized Controlled Clinical Trial.

Effects of N-3 Fatty Acid Supplements on Glycemic Traits in Chinese Type 2 Diabetic Patients: A Double-Blind Randomized Controlled Trial.

Dietary camellia (<i>Camellia oleifera</i> Abel) seed oil in traditional Chinese cooking for high-risk cardiovascular disease: A three-arm double-blind randomized controlled feeding trial protocol

Effects of Plant Oils with Different Fatty Acid Composition on Cardiovascular Risk Factors in Moderately Hypercholesteremic Chinese Adults: a Randomized, Double-Blinded, Parallel-Designed Trial

Effect of Lard Plus Soybean Oil on Blood Pressure and Other Cardiometabolic Risk Factors in Healthy Subjects: a Randomized Controlled-Feeding Trial

Serum metabolomics profiles in response to n-3 fatty acids in Chinese patients with type 2 diabetes: a double-blind randomised controlled trial

Changes of urine metabolites in response to n-3 fatty acid supplements and their correlation with metabolic risk factors in patients with type 2 diabetes.

A Comparative Study of the Effects of Palm Olein, Cocoa Butter and Extra Virgin Olive Oil on Lipid Profile, Including Low-Density Lipoprotein Subfractions in Young Healthy Chinese People.

Change Of Plasma Metabolites In Response To Omega-3 Fatty Acids In Chinese Patients With Type 2 Diabetes: A Double-Blinded Randomized Controlled Trial

Effect of Plant-Derived n-3 Polyunsaturated Fatty Acids on Blood Lipids and Gut Microbiota: A Double-Blind Randomized Controlled Trial

The Effect of MUFA-Rich Food on Lipid Profile: A Meta-Analysis of Randomized and Controlled-Feeding Trials.

Effects of Palm Olein and Olive Oil on Serum Lipids in a Chinese Population: a Randomized, Double-Blind, Cross-over Trial.

Effects of Macronutrient Distribution on Weight and Related Cardiometabolic Profile in Healthy Non-Obese Chinese: A 6-month, Randomized Controlled-Feeding Trial.

N-3 Polyunsaturated Fatty Acids and Metabolic Syndrome Risk: A Meta-Analysis

Normal Fat Intake with High MUFA Content and an Appropriate SFA/MUFA/PUFA Ratio Improved the Health of Rats

Effects of Fish Oil-Derived Fatty Acids on Suboptimal Cardiovascular Health: A Multicenter, Randomized, Double-Blind, Placebo-Controlled Trial.

The effects of low-ratio n-6/n-3 PUFA on biomarkers of inflammation: a systematic review and meta-analysis